Radcliffe Capital Management’s Science Strategic Acquisition Corp. Alpha Warrant SSAAW Stock Holding History

Radcliffe Capital Management’s Portfolio SSAAW Stock Details SSAAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-177,841	Closed	-$1.75M	–	1080
2022 Q3	$1.75M	Hold	177,841	–	–	0.04%	712
2022 Q2	$1.75M	Hold	177,841	–	–	0.04%	746
2022 Q1	$1.75M	Hold	177,841	–	–	0.04%	720
2021 Q4	$1.73M	Hold	177,841	–	–	0.05%	625
2021 Q3	$1.73M	Hold	177,841	–	–	0.05%	525
2021 Q2	$1.73M	Buy	+177,841	New	+$134K	0.05%	553

Radcliffe Capital Management's SSAAW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of Science Strategic Acquisition Corp. Alpha Warrant (SSAAW) in Q4 2022, closing a stake of 177,841 shares — an estimated $1.75M sold.

Radcliffe Capital Management first reported a position in SSAAW in Q2 2021 and held it in 6 quarters. The position peaked at $1.75M in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAAW as of Q4 2022.

Radcliffe Capital Management reported no remaining Science Strategic Acquisition Corp. Alpha Warrant position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 177,841 Science Strategic Acquisition Corp. Alpha Warrant shares in Q4 2022, an estimated $1.75M.
Radcliffe Capital Management first reported a position in Science Strategic Acquisition Corp. Alpha Warrant in Q2 2021 and held it in 6 quarters.
Radcliffe Capital Management's Science Strategic Acquisition Corp. Alpha Warrant position peaked at $1.75M in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.